Recent studies have reported that prostate cancer risk-associated G allele of rs11672691 is associated with an increased expression of lincRNA PCAT19 and oncogene CEACAM21; SNV rs11672691 is located in an enhancer element and may alter the binding site of its oncogenic transcription factor HOXA2. This evidence concerns the gene CEACAM21 and Familial prostate cancer.